RAINMED MEDICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.153 HKD | -7.27% |
|
-11.05% | -64.42% |
| Mar. 28 | Rainmed Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Rainmed Medical Limited announces Change of Principal Place of Business in Hong Kong | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Rainmed Medical Ltd is a China-based investment holding company. The Company is primarily engaged in research and development, manufacturing and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) system and coronary angiography-derived index of microvascular resistance (caIMR) system. The Companyâs core products, caFFR system and caIMR system, are innovative medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). They are designed to eliminate the usage of pressure wires, significantly reduce the risk of technical errors and operation time, and improve physiological assessment. The Company mainly operates its businesses in the domestic and overseas markets.
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -64.42% | 24.61M | |
| +3.95% | 3.46B | |
| -11.53% | 158M | |
| -15.28% | 82.43M | |
| +30.43% | 59.56M |
- Stock Market
- Equities
- 2297 Stock
- News Rainmed Medical Limited
- Ping An-Backed Rainmed Prices Hong Kong IPO at Top of Range, Raises $10 Million
